1Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta,Georgia.
3Department of Epidemiology,Johns Hopkins University Bloomberg School of Public Health Baltimore,Maryland.
Infect Control Hosp Epidemiol. 2018 Jan;39(1):1-11. doi: 10.1017/ice.2017.236. Epub 2017 Dec 18.
OBJECTIVE To describe pathogen distribution and antimicrobial resistance patterns for healthcare-associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) from pediatric locations during 2011-2014. METHODS Device-associated infection data were analyzed for central line-associated bloodstream infection (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia (VAP), and surgical site infection (SSI). Pooled mean percentage resistance was calculated for a variety of pathogen-antimicrobial resistance pattern combinations and was stratified by location for device-associated infections (neonatal intensive care units [NICUs], pediatric intensive care units [PICUs], pediatric oncology and pediatric wards) and by surgery type for SSIs. RESULTS From 2011 to 2014, 1,003 hospitals reported 20,390 pediatric HAIs and 22,323 associated pathogens to the NHSN. Among all HAIs, the following pathogens accounted for more than 60% of those reported: Staphylococcus aureus (17%), coagulase-negative staphylococci (17%), Escherichia coli (11%), Klebsiella pneumoniae and/or oxytoca (9%), and Enterococcus faecalis (8%). Among device-associated infections, resistance was generally lower in NICUs than in other locations. For several pathogens, resistance was greater in pediatric wards than in PICUs. The proportion of organisms resistant to carbapenems was low overall but reached approximately 20% for Pseudomonas aeruginosa from CLABSIs and CAUTIs in some locations. Among SSIs, antimicrobial resistance patterns were similar across surgical procedure types for most pathogens. CONCLUSION This report is the first pediatric-specific description of antimicrobial resistance data reported to the NHSN. Reporting of pediatric-specific HAIs and antimicrobial resistance data will help identify priority targets for infection control and antimicrobial stewardship activities in facilities that provide care for children. Infect Control Hosp Epidemiol 2018;39:1-11.
描述 2011-2014 年向国家医疗保健安全网络(NHSN)报告的儿科医疗机构获得性感染(HAI)的病原体分布和抗菌药物耐药模式。
对中心静脉导管相关血流感染(CLABSI)、导尿管相关尿路感染(CAUTI)、呼吸机相关肺炎(VAP)和手术部位感染(SSI)的器械相关感染数据进行分析。针对各种病原体-抗菌药物耐药模式组合,计算了合并平均耐药率,并按器械相关感染(新生儿重症监护病房[NICU]、儿科重症监护病房[PICU]、儿科肿瘤病房和儿科病房)的部位和手术类型(SSI)进行分层。
2011 年至 2014 年,有 1003 家医院向 NHSN 报告了 20390 例儿科 HAI 和 22323 例相关病原体。在所有 HAI 中,以下病原体占报告病原体的 60%以上:金黄色葡萄球菌(17%)、凝固酶阴性葡萄球菌(17%)、大肠埃希菌(11%)、肺炎克雷伯菌和/或产酸克雷伯菌(9%)和粪肠球菌(8%)。在器械相关感染中,NICU 的耐药率通常低于其他部位。对于几种病原体,儿科病房的耐药率高于 PICU。总的来说,对碳青霉烯类药物耐药的病原体比例较低,但在某些地区,CLABSI 和 CAUTI 中铜绿假单胞菌的耐药率达到约 20%。在 SSI 中,大多数病原体的手术类型之间的抗菌药物耐药模式相似。
本报告是 NHSN 报告的首个儿科特定的抗菌药物耐药数据描述。报告儿科特定的 HAI 和抗菌药物耐药数据将有助于确定为儿童提供医疗保健的设施中感染控制和抗菌药物管理活动的优先目标。感染控制与医院流行病学 2018;39:1-11。